250 related articles for article (PubMed ID: 33360229)
1. From incomplete to complete systemic lupus erythematosus; A review of the predictive serological immune markers.
Lambers WM; Westra J; Bootsma H; de Leeuw K
Semin Arthritis Rheum; 2021 Feb; 51(1):43-48. PubMed ID: 33360229
[TBL] [Abstract][Full Text] [Related]
2. Brief Report: How Do Patients With Newly Diagnosed Systemic Lupus Erythematosus Present? A Multicenter Cohort of Early Systemic Lupus Erythematosus to Inform the Development of New Classification Criteria.
Mosca M; Costenbader KH; Johnson SR; Lorenzoni V; Sebastiani GD; Hoyer BF; Navarra S; Bonfa E; Ramsey-Goldman R; Medina-Rosas J; Piga M; Tani C; Tedeschi SK; Dörner T; Aringer M; Touma Z
Arthritis Rheumatol; 2019 Jan; 71(1):91-98. PubMed ID: 30035365
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies.
Lu R; Munroe ME; Guthridge JM; Bean KM; Fife DA; Chen H; Slight-Webb SR; Keith MP; Harley JB; James JA
J Autoimmun; 2016 Nov; 74():182-193. PubMed ID: 27338520
[TBL] [Abstract][Full Text] [Related]
4. Interferon score is increased in incomplete systemic lupus erythematosus and correlates with myxovirus-resistance protein A in blood and skin.
Lambers WM; de Leeuw K; Doornbos-van der Meer B; Diercks GFH; Bootsma H; Westra J
Arthritis Res Ther; 2019 Dec; 21(1):260. PubMed ID: 31791398
[TBL] [Abstract][Full Text] [Related]
5. Serum profiling identifies CCL8, CXCL13, and IL-1RA as markers of active disease in patients with systemic lupus erythematosus.
Lindblom J; Beretta L; Borghi MO; ; Alarcón-Riquelme ME; Parodis I
Front Immunol; 2023; 14():1257085. PubMed ID: 38098483
[TBL] [Abstract][Full Text] [Related]
6. Rowell Syndrome in Nigeria: Systemic Lupus Erythematosus Presenting as Recurrent Erythema Multiforme in a Young Woman.
Akintayo RO; Olarinoye GM; Akintayo FC; Ilesanmi ON
Acta Dermatovenerol Croat; 2019 Sep; 27(3):200-201. PubMed ID: 31542069
[TBL] [Abstract][Full Text] [Related]
7. Clinical patterns of disease: From early systemic lupus erythematosus to late-onset disease.
Piga M; Tselios K; Viveiros L; Chessa E; Neves A; Urowitz MB; Isenberg D
Best Pract Res Clin Rheumatol; 2023 Dec; 37(4):101938. PubMed ID: 38388232
[TBL] [Abstract][Full Text] [Related]
8. Clinical application of protein biomarkers in lupus erythematosus and lupus nephritis.
Qi S; Chen Q; Xu D; Xie N; Dai Y
Lupus; 2018 Sep; 27(10):1582-1590. PubMed ID: 29720035
[TBL] [Abstract][Full Text] [Related]
9. Advances in the diagnosis and classification of systemic lupus erythematosus.
Larosa M; Iaccarino L; Gatto M; Punzi L; Doria A
Expert Rev Clin Immunol; 2016 Dec; 12(12):1309-1320. PubMed ID: 27362864
[TBL] [Abstract][Full Text] [Related]
10. Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE): study protocol for a randomized controlled trial.
Olsen NJ; James JA; Arriens C; Ishimori ML; Wallace DJ; Kamen DL; Chong BF; Liao D; Chinchilli VM; Karp DR
Trials; 2018 Dec; 19(1):694. PubMed ID: 30572906
[TBL] [Abstract][Full Text] [Related]
11. New insights into the progression from cutaneous lupus to systemic lupus erythematosus.
Zhou W; Wu H; Zhao M; Lu Q
Expert Rev Clin Immunol; 2020 Aug; 16(8):829-837. PubMed ID: 32746644
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic criteria for systemic lupus erythematosus: has the time come?
Bertsias GK; Pamfil C; Fanouriakis A; Boumpas DT
Nat Rev Rheumatol; 2013 Nov; 9(11):687-94. PubMed ID: 23838616
[TBL] [Abstract][Full Text] [Related]
13. IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production.
Pan Q; Xiao H; Shi L; He Y; Cai J; Wu J; Li A; Ye L; Yang C; Liu HF
Front Immunol; 2020; 11():1047. PubMed ID: 32625200
[TBL] [Abstract][Full Text] [Related]
14. Incomplete Systemic Lupus Erythematosus: What Remains After Application of American College of Rheumatology and Systemic Lupus International Collaborating Clinics criteria?
Lambers WM; Westra J; Jonkman MF; Bootsma H; de Leeuw K
Arthritis Care Res (Hoboken); 2020 May; 72(5):607-614. PubMed ID: 30932354
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic criteria for systemic lupus erythematosus: a critical review.
Yu C; Gershwin ME; Chang C
J Autoimmun; 2014; 48-49():10-3. PubMed ID: 24461385
[TBL] [Abstract][Full Text] [Related]
16. The natural history of pediatric-onset discoid lupus erythematosus.
Arkin LM; Ansell L; Rademaker A; Curran ML; Miller ML; Wagner A; Kenner-Bell BM; Chamlin SL; Mancini AJ; Klein-Gitelman M; Paller AS
J Am Acad Dermatol; 2015 Apr; 72(4):628-33. PubMed ID: 25648823
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to C-reactive protein in incomplete lupus and systemic lupus erythematosus.
Jung JY; Koh BR; Kim HA; Jeon JY; Suh CH
J Investig Med; 2014 Aug; 62(6):890-3. PubMed ID: 24896736
[TBL] [Abstract][Full Text] [Related]
18. A Contemporary Update on the Diagnosis of Systemic Lupus Erythematosus.
Huang X; Zhang Q; Zhang H; Lu Q
Clin Rev Allergy Immunol; 2022 Dec; 63(3):311-329. PubMed ID: 35064901
[TBL] [Abstract][Full Text] [Related]
19. Lupus: the new epidemic.
Ugarte-Gil MF; González LA; Alarcón GS
Lupus; 2019 Aug; 28(9):1031-1050. PubMed ID: 31299878
[TBL] [Abstract][Full Text] [Related]
20. Humanized Mouse Models of Systemic Lupus Erythematosus: Opportunities and Challenges.
Chen J; Liao S; Zhou H; Yang L; Guo F; Chen S; Li A; Pan Q; Yang C; Liu HF; Pan Q
Front Immunol; 2021; 12():816956. PubMed ID: 35116040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
